Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic Control and Lowers Body Weight in Patients With Typ...

por Nauck, Michael A., Ratner, Robert E., Kapitza, Christoph, Berria, Rachele, Boldrin, Mark, Balena, Raffaella
Publicado 2009

Efficacy and Safety of Taspoglutide Monotherapy in Drug-Naive Type 2 Diabetic Patients After 24 Weeks of Treatment: Results of a randomized, double-blind, placebo-controlled phase...

por Raz, Itamar, Fonseca, Vivian, Kipnes, Mark, Durrwell, Laurence, Hoekstra, John, Boldrin, Mark, Balena, Raffaella
Publicado 2012

Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial)

por Bergenstal, Richard M., Forti, Adriana, Chiasson, Jean-Louis, Woloschak, Michael, Boldrin, Mark, Balena, Raffaella
Publicado 2012

The Fate of Taspoglutide, a Weekly GLP-1 Receptor Agonist, Versus Twice-Daily Exenatide for Type 2 Diabetes: The T-emerge 2 trial

por Rosenstock, Julio, Balas, Bogdan, Charbonnel, Bernard, Bolli, Geremia B., Boldrin, Mark, Ratner, Robert, Balena, Raffaella
Publicado 2013